Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi vs Menveo in Healthy Children 2-9 Years
NCT03077438Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2017
- Primary completion
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, meningococcal meningitis, sponsored by Sanofi. Started Feb 2017; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infectionmeningococcal meningitis
Beyond the preview
Go deeper on NCT03077438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03077438.